Amgen Delivers On Launch Of First US Humira Rival – At A 55% Discount
Amjevita Biosimilar Version Of Adalimumab Has Six Months With The Market To Itself
• By David Wallace
Amgen is leading off US biosimilar competition to Humira • Source: Shutterstock 
